Diffusion-weighted imaging (DWI) of the spleen in patients with liver cirrhosis and portal hypertension

Magnetic Resonance Imaging

Volumn 31, Issue 7, 2013, Pages 1092-1096

  Klasen, Janina ^a   Lanzman, Rotem Shlomo ^a   Wittsack, Hans Jörg ^a   Kircheis, Gerald ^a   Schek, Julia ^a   Quentin, Michael ^a   Antoch, Gerald ^a   Häussinger, Dieter ^a   Blondin, Dirk ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

ADC; DWI; Liver cirrhosis; MRI; Portal hypertension; Spleen

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; CHILD PUGH SCORE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; LIVER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PORTOCAVAL SHUNT; PRIORITY JOURNAL; REPRODUCIBILITY; RETROSPECTIVE STUDY; SPLEEN; SPLEEN SIZE; STOMACH DISEASE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

EID: 84880739821     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2013.01.003     Document Type: Article

References (26)

1. Groszmann R.J., Abraldes J.G. Portal hypertension: from bedside to bench. J Clin Gastroenterol 2005, 39(Suppl. 2):S125-S130.
2. Gibson P.R., Gibson R.N., Ditchfield M.R., Donlan J.D. Splenomegaly: an insensitive sign of portal hypertension. Aust N Z J Med 1990, 20:771-774.
3. Merkel C., Gatta A., Arnaboldi L., Zuin R. Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement. Clin Physiol 1985, 5:531-539.
4. Sheth S.G., Amarapurkar D.N., Chopra K.B., Mani S.A., Mehta P.J. Evaluation of splenomegaly in portal hypertension. J Clin Gastroenterol 1996, 22:28-30.
5. Lafortune M., Marleau D., Breton G., Viallet A., et al. Portal venous system measurements in portal hypertension. Radiology 1984, 151(1):27-30.
6. Shi B.-M., Wang X.-Y., Qing-Ling M., Tai-Huang W., Jian X. Value of portal hemodynamics and hypersplenism in cirrhosis staging. World J Gastroenterol 2005 February 7, 11(5):708-711.
7. Koinuma M., Ohashi I., Hanafusa K., Shibuya H. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 2005, 22:80-85.
8. Lewin M., Poujol-Robert A., Boelle P.Y., et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007, 46:658-665.
9. Taouli B., Tolia A.J., Losada M., et al. Diffusion weighted MRI for quantification of liver fibrosis: preliminary experience. AJR 2007, 189:799-806.
10. Girometti R., Furlan A., Esposito G., et al. Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences. J Magn Reson Imaging 2008, 28:411-419.
11. Taouli B., Chouli M., Martin A.J., Qayyum A., Coakley F.V., Vilgrain V. Chronic hepatitis: role of diffusion weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 2008, 28:89-95.
12. Braithwaite A.C., Dale B.M., Boll D.T., Merkle E.M. Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology 2009, 250:459-465.
13. Sasaki M., Yamada K., Watanabe Y., et al. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 2008, 249:624-630.
14. Koh D.M., Blackledge M., Collins D.J., et al. Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 2009, 19:2728-2738.
15. Kim T., Murakami T., Takahashi S., Hori M., Tsuda K., Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR 1999, 173:393-398.
16. Papanikolaou N., Gourtsoyianni S., Yarmenitis S., Maris T., Gourtsoyiannis N. Comparison between two-point and four-point methods for quantification of apparent diffusion coefficient of normal liver parenchyma and focal lesions: value of normalization with spleen. Eur J Radiol 2010, 73:305-309.
17. Do R.K., Chandanara H., Felker E., Hajdu C.H., Babb J.S., Kim D., et al. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR 2010, 195:671-676.
18. Talwalkar J.A., Yin M., Venkatesh S., Rossman P.J., Grimm R.C., et al. Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR 2009, 193:122-127.
19. Nedredal G.I., Yin M., McKenzie T., Lillegard J., Luebke-Wheeler J., et al. Portal hypertension correlates with splenic stiffness as measured with MR elastography. J Magn Reson Imaging 2011, 34:79-87.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174, 197.
21. Desmet V.J., Gerber M., Hoofnagle J.H., et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994, 19:1513-1520.
22. Koh D.M., Collins D. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR 2007, 188:1622-1635.
23. Le Bihan D., Breton E., Lallemand D., et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988, 168:497-505.
24. Yoshikawa T., Kawamitsu H., Mitchell D.G., et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR 2006, 187:1521-1530.
25. Yamada I., Aung W., Himeno Y., et al. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-panar MR imaging. Radiology 1999, 210:617-623.
26. Park S.O., Kim J.K., Kim K.A., et al. Relative apparent diffusion coefficient: determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer. J Magn Reson Imaging 2009, 29(2):383-390.